The necessity for financial analysis is growing as a result of industrialization, trade, and commerce. Predicting financial difficulties has become a key concern for all firms since the financial crisis happened in 2008. For assessing a company's financial health and the likelihood of insolvency, employ Altman’s Z-score model. Early bankruptcy prediction is vital for both the parties involved in the company and society. Based on their sales in the year 2021-2022, the top five pharmaceutical companies listed on the Bombay Stock Exchange were chosen as a sample for this study. The period of the study is five years, from 2017-2018 to 2021-2022. For this study, secondary data is employed. The collected data was examined by using Altman's "Z" score model in Microsoft Excel. The results show that the average Z-score for the pharmaceutical sector over the course of the study was greater than 4.5, which is significantly greater than the threshold value of 1.8 and indicates that the sector's overall financial position is satisfactory.